Strain for the treatment and/or prevention of chronic inflammatory diseases
AssigneesLesaffre Et Compagnie, Ecole Nationale Superieure Des Sciences Agronomiques De Bordeaux Aquitaine (Borde Aux Sciences Agro)
InventorsPatrick Taillade, Maria Urdaci
Life of this patent
Estimating the term…
Abstract
The present invention concerns the probiotic strain Bacillus subtilis CU1 filed with the French Collection Nationale de Culture des Microorganismes (National Collection of Microorganism Cultures) under number I-2745, cells obtained by culturing said strain and a composition comprising cells obtained by culturing said strain, for the use thereof in the treatment and/or prevention of chronic inflammatory diseases, and in particular chronic inflammatory rheumatism.
Claims17
A method for treating a chronic inflammatory diseases in a patient or for delaying an inflammatory flare-up in a chronic inflammatory rheumatism patient, the method comprising administering to the patient an effective amount of Bacillus subtilis strain CU1 filed with the CNCM under number I-2745 on Oct. 25, 2001, to the exclusion of any other strain of bacterium.
A method for treating a chronic inflammatory diseases in a patient or for delaying an inflammatory flare-up in a chronic inflammatory rheumatism patient, the method comprising administering to the patient an effective amount of cells obtained by culturing the Bacillus subtilis strain CU1 filed with the CNCM under number I-2745 on Oct. 25, 2001, to the exclusion of any other strain of bacterium.
A method for treating a chronic inflammatory diseases in a patient or for delaying an inflammatory flare-up in a chronic inflammatory rheumatism patient, the method comprising administering to the patient an effective amount of a composition comprising cells obtained by culturing the Bacillus subtilis strain CU1 filed with the CNCM under number I-2745 on Oct. 25, 2001, to the exclusion of any other strain of bacterium.
Dependencies are inferred from the claim text.